baber/WOPTO huggingface dataset:
Patent NZ-245387-A (NZ)
Title: Heat- treatable glass coated with ni-containing and oxide layers
Inventor: HARTIG KLAUS W
IPC: C23C14/08
Filed: 1992-12-07
Abstract: A heat treatable sputter-coated layer system for glass substrates may be applied before heat treatment if the layer system includes a metallic layer (C) of nickel or a high nickel content alloy covered by separate layers (B,D)  of metallic silicon or an oxide or nitride of nickel or the high nickel content alloy, which in turn is covered by a protective metal oxide such as stoichiometric Sn 02(layers A,E).   <IMAGE>
Patent NZ-254503-A (NZ)
Title: Peptide pulmonary surfactants and compositions thereof
Inventor: MCLEAN LARRY RAYMOND
IPC: C07K5/113
Filed: 1993-07-01
Abstract: Synthetic pulmonary surfactant consisting of a complex of a polypeptide of 3-4 amino acid residues having alpha-helical structure and a covalently bound long chain acyl group. The peptides are useful when consisting of one or more associated lipids in combination in conditions associated with respiratory distress.
Patent NZ-254688-A (NZ)
Title: Lol p v grass pollen allergens, peptides containing t-cell binding sites, detection of sensitivity, antibodies and recombinant production of the allergens
Inventor: KNOX ROBERT BRUCE
IPC: A61K38/08
Filed: 1993-08-13
Abstract: The present invention provides isolated peptides of Lol p V, a major protein allergen of the species Lolium perenne. Therapeutic peptides within the scope of the invention comprise at least on T cell epitope, or preferably at least two T cell epitopes of a protein allergen of Lol p V. Diagnostic peptides within the scope of the invention bind IgE. The invention also provides modified peptides having similar or enhanced therapeutic properties as the corresponding, naturally-occurring allergen or portion thereof, but having reduced side effects. The invention further provides nucleic acid sequences coding for peptides of the invention. Methods of treatment or diagnosis of sensitivity to Lol p V or an allergen immunologically related to Lol p V in an individual. Therapeutic compositions comprising one or more peptides of the invention are also provided.
Patent NZ-257679-A (NZ)
Title: Ground-surface levelling device; incorporates a frame which carries a planing or grading tool attached to a road working machine; bogie assembly details
Inventor: NILSSON LENNART
IPC: E02F3/96
Filed: 1993-11-05
Abstract: PCT No. PCT/SE93/00931 Sec. 371 Date Feb. 12, 1996 Sec. 102(e) Date Feb. 12, 1996 PCT Filed Nov. 5, 1993 PCT Pub. No. WO94/11584 PCT Pub. Date May 26, 1994The present invention relates to an apparatus for use in conjunction with a machine, such as a wheel-mounted loader, road planing machine or the like, to equalize the effect of ground-surface irregularities. The apparatus includes a frame disposed in the movement direction of the machine and a planing tool. The apparatus also includes a bogie-assembly which is mounted on the front end of the frame and extends parallel to the frame. The bogie-assembly includes two pivot wheels and a linking device which is pivotally mounted between the frame and an intermediate unit connected to the planing tool.
Patent NZ-281137-A (NZ)
Title: Carrying case with detachable step stool
Inventor: CARR ARTHUR G
IPC: E06C1/39
Filed: 1995-02-15
Abstract: A carrying case assembly includes a carrying case portion provided with a first interior cavity and a first top opening and a step stool portion provided with a second interior space and a bottom opening. The bottom of the step stool portion is attached to the top of the carrying case portion such that the first and the second interior space, together, form a third interior space. The step stool portion is removable from the carrying case portion and is adapted to support a person thereon.
Patent NZ-297174-A (NZ)
Title: Substituted 4-biarylbutyric or 5-pentanoic acids useful as matrix metalloprotease inhibitors
Inventor: KLUENDER HAROLD CLINTON EUGENE
IPC: C07D277/74
Filed: 1995-11-09
Abstract: A 4-biarylbutyric or 5-pentanoic acid derivative has the formula (I) (T)xA-B-D-E-G or pharmaceutically acceptable salts thereof wherein: A represents an optionally substituted aromatic or heteroaromatic moiety of formula (2); R1 is H or alkyl; each T is halogen, alkyl, haloalkyl, alkenyl, alkynyl, -(CH2)pQ or -alkenyl-Q; p is 0 to 4; x is 0, 1, or 2; B is an optionally substituted aromatic or heteroaromatic moiety of formula (3); D represents -C(=O)-, -C(OH)(H)-, -C(=NOH)- or -C(=S)-; E represents a chain of n carbon atoms bearing m substituents R6; each group R6 is independently of: i) alkyl provided that if the A unit is phenyl, the B unit is phenylene, m is 1, n is 2, and the alkyl group is located on the alpha carbon relative to the D unit, then x is 1 or 2 but if the alkyl group is located in the beta carbon relative to the D unit then the alkyl group contains 4-10 carbons; j) aryl of 6 - 10 carbons, provided that if the A unit is phenyl, the B unit is phenylene, the aryl group is phenyl, n is 2, and m is 1 or 2, then x is 1 or 2; k) heteroaryl having at least one N, O, or S heteroatom; l) arylalkyl; m) heteroaryl-alkyl having at least one N, O, or S heteroatom; n) alkenyl; o) aryl-alkenyl; p) heteroaryl-alkenyl at least one N, O, or S heteroatom; q) alkynyl; r) aryl-alkynyl; s) heteroaryl-alkynyl having at least one N, O, or S heteroatom; t) -(CH2)tR7; u) -(CH2)vZR8 and v) -(CH2)wSiR10 or two groups of R6 together can form with the chain atom(s) to which they are attached, and any intervening chain atoms, constitute a 3 - 7 membered ring, or one group R6 can form together with the chain atom(s) to which it is attached, and any intervening chain atoms, constitutes a 3 - 7 membered ring with the number of carbons in the totality of R6 groups is at least two; n is 2 or 3; m is 1 to 3; G is -M, or a group of formula (4); M is -CO2H, -CON(R11)2 or -CO2R12; R13 is any of the side chains of the 19 noncyclic naturally occurring amino acid and Q, R7, t, v, Z, R8, w and R10 to R12 are as defined in the specification. A pharmaceutical composition having matrix metalloprotease inhibitory activity thereof is useful for the alleviation of osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurismal aortic disease, dystrophobic epidermolysis bullosa, conditions leading to inflammatory responses, osteopenias mediated by MMP activity, tempero mandibular joint disease, or demyelating diseases of the nervous system; retardation of tumor metastasis or degenerative cartilage loss following traumatic joint injury; reduction of coronary thrombosis from atherosclerotic plaque rupture; or improved birth control.
Patent NZ-310734-A (NZ)
Title: Herbicidal compositions comprising encapsulated clomazone dissolved in an inert high boiling organic solvent
Inventor: STERN ALAN J
IPC: A01N43/80
Filed: 1996-06-04
Abstract: There is provided and aqueous dispersion of microcapsules containing the herbicide clomazone dissolved in an inert high boiling organic solvent. Vapor transfer of the herbicide outside the targeted area is controlled without substantial sacrifice of the efficacy of the herbicide.
Patent NZ-333752-A (NZ)
Title: Intradermal bovine polynucleotide vaccine comprising BRSV, IBR, BVD and PI-3 viruses
Inventor: RIJSEWIJK FRANCISCUS ANTONIUS
IPC: C12N15/85
Filed: 1997-07-16
Abstract: The vaccine comprises 10 ng to 1 mg of a plasmid consisting of a combination of a DNA sequence coding for a bovine pathogen immunogen and a promoter enabling in vivo expression of this immunogen in skin cells.  The pathogenic agents are chosen from the group of BRSV virus, IBR virus, BVD virus and PI 3 virus.  An example of a suitable promoter is the hCMV IE promoter. The vaccine formula can be delivered to the animal using a portable bovine vaccination unit, comprising an apparatus for liquid jet delivery of the vaccine, a vial suitable to hold several doses of the vaccine and a discharge head with 1 to 10 nozzles.
Patent NZ-335651-A (NZ)
Title: Aryl or heteroaryl sustituted 3,4-dihydroanthracene and aryl or heteroaryl sustituted benzo[1,2-g]-chrom-3-ene, benzo[1,2,-g]-thiochrom-3-ene and benzo[1,2-g]-dihydroquinoline derivatives having retinoid anatgonist or retinoid inverse agonist type biological activity
Inventor: VULIGONDA VIDYASAGAR
IPC: C07D417/02
Filed: 1997-12-09
Abstract: A compound of the formula above wherein X1 is --S--, --O--, --C(R1)2 --O-- or --C(R1)2 --S--; R1 is independently H or alkyl of 1 to 6 carbons; R2 is optional and is defined as lower alkyl of 1 to 6 carbons, F, Cl, Br, I, CF3, fluoro substituted alkyl of 1 to 6 carbons, OH, SH, alkoxy of 1 to 6 carbons, or alkylthio of 1 to 6 carbons; m is an integer between 0 and 4; n is an integer between 0 and 2; o is an integer between 0 and 3; R3 is hydrogen, lower alkyl of 1 to 6 carbons, F, Cl, Br or I; R4 is phenyl, (R5)p -phenyl, naphthyl, (R5)p -naphthyl, pyridyl, (R5)p -pyridyl, thienyl or (R5)-thienyl; p is an integer having the values of 1-5; R5 is independently F, C, Br, I, NO2, N(R8)2, N(R8)COR8, NR8 CON(R8)2, OH, OCOR8, OR8, CN, COOH, COOR8 an alkyl group having 1 to 10 carbons, fluoro substituted alkyl group having 1 to 10 carbons, an alkenyl group having 1 to 10 carbons and 1 to 3 double bonds, alkynyl group having 1 to 10 carbons and 1 to 3 triple bonds, or a (trialkyl)silyl or (trialkyl)silyloxy group where the alkyl groups independently have 1 to 6 carbons; Y is a phenyl or naphthyl group, or heteroaryl selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl and pyrrazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted with one or two R2 groups, or Y is --(CR3=CR3)r --; r is an integer between 1 and 3; A is (CH1)q where q is 0-5, lower branched chain alkyl having 3-6 carbons, cycloalkyl having 3-6 carbons, alkenyl having 2-6 carbons and 1 or 2 double bonds, alkynyl having 2-6 carbons and 1 or 2 triple bonds, with the proviso that when Y is --(CR3=CR3)r -- then A is (CH2)q and q is 0; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR8, CONR9 R10, --CH2 OH, CH2 OR11, CH2 OCOR11, CHO, CH(OR12)2, CHOR13 O, --COR7, CR7 (OR12)2, CR7 OR13 O, or Si(C1-6 alkyl)3, where R7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R8 is phenyl or lower alkylphenyl, R9 and R10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R11 is lower alkyl, phenyl or lower alkylphenyl, R12 is lower alkyl, and R13 is divalent alkyl radical of 2-5 carbons. These compounds have retinoid, retinoid antagonist and/or retinoid inverse-agonist-like biological activity.
Patent NZ-337457-A (NZ)
Title: Synthesis of long chain polyunsaturated fatty acids, omega-3 and omega-6 fatty acids, specifically eicosapentaenoic acid and arachidonic acid
Inventor: KNUTZON DEBORAH
IPC: A23K1/16
Filed: 1998-04-10
Abstract: Fatty acid desaturases able to catalyze the conversion of oleic acid to linoleic acid, linoleic acid to gamma-linolenic acid, or of alpha-linolenic acid to stearidonic acid. Nucleic acid sequences encoding fatty acid desaturases, DNA constructs comprising a desaturase gene, and recombinant host microorganism or animal expressing increased levels of a desaturase is described. Methods for desaturating a fatty acid and for producing a desaturated fatty acid by expressing increased levels of a desaturase are disclosed. Fatty acids, and oils containing them, which have been desaturated by a desaturase produced by recombinant host microorganisms or animals are provided. Pharmaceutical compositions, infant formulas or dietary supplements containing fatty acids which have been desaturated by a desaturase produced by a recombinant host microorganism or animal also are described.
Patent NZ-501272-A (NZ)
Title: Grinding machine with rotating casing having discs and belt and gear drives to discs
Inventor: WITTERS GILBERT FILIPE MARIA
IPC: B24B41/047
Filed: 1998-05-27
Abstract: A grinding machine comprises a frame having a rotary casing that bears rotary holders for grinding discs, as well as a drive motor which is mounted on the frame and interacts with the casing and the holders to drive the machine. The drive motor is connected by means of a continuous flexible or articulated element to the holders for driving the latter in the direction of rotation, wherein at least one of the holders is coupled to the frame by means of a gear transmission, in order to bring the casing into rotation when said holder is driven.
Patent NZ-509692-A (NZ)
Title: Scissors formed from bows that are symmetrical about central longitudinal plane and having outer ends formed of resilient material
Inventor: STOKES ANDREW JOHN
IPC: B26B13/20
Filed: 2001-02-01
Abstract: At least thumb bow 5 has forward end 7 (towards pivot 4) formed of rigid material and a rearward part 8 formed of a resilient material. This allows for sideways flexing of thumb and finger bows 5,6 which is stated to provide comfortable right-handed and left-handed operation.
Patent NZ-511238-A (NZ)
Title: Method of providing cosmetic/medical therapy
Inventor: ORTON KEVIN R
IPC: A61P31/12
Filed: 1999-12-02
Abstract: A method for preparing and use of a substance (18). The preparation involves flowing an alternating electrical current through an electrolytic material. The alternating current is caused to flow for a period preferably at least 10 minutes, and more preferably 4-8 hours, so as to change a physical property thereof. The current is then removed. The substance has properties which last for a limited time. While active, the substances may then be used to provide medical/cosmetic therapy to a recipient by inhaling into the pulmonary tract, or internal injection of the substance into the body of a human or animal recipient.
Patent NZ-511812-A (NZ)
Title: Method of lowering lipid, triglyceride, total cholesterol and LDL-cholesterol serum levels and increasing the HDL/LDL cholesterol ratio thereby treating cardiovascular disease
Inventor: HOIE LARS HENRIK
IPC: A23L1/30
Filed: 1999-11-25
Abstract: Described is a composition comprising (a) soy protein, (b) a phytoestrogen compound, and (c) dietary fibres. The soy protein (a) is present in an amount of at least 45 weight percent of the total protein content of the composition, the total protein content providing at least 15 percent of the total energy content of the composition. The phytoestrogen compound (b) is preferably a naturally occurring isoflavone and is present in an amount of more than 0.10 weight percent of the soy protein, and the dietary fibres (c) are preferably soybean fibres and are present in an amount of more than 4 weight percent of the total weight of the nutritional composition on a dry basis. The composition is useful in lowering serum cholesterol and LDL-cholesterol and serum triglyceride levels and for increasing the HDL/LDL-cholesterol ratio in serum of a subject suffering from atherosclerosis, arteriosclerosis and related cardiovascular diseases.
Patent NZ-512731-A (NZ)
Title: Tricyclic inhibitors of poly(ADP-ribose) polymerases
Inventor: WEBBER STEPHEN EVAN
IPC: C07D519/00
Filed: 2000-01-10
Abstract: A compound or a pharmaceutically acceptable salt or solvate thereof has the formula (I), (II) or (III) wherein: R1 is H, halogen, cyano or an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl group, or -C(O)-R10, OR100 or NR100R110; R2, R3, R11, R13 and R17 are independently H or alkyl; X is O or S; Y is (CR5R6)(CR7R8)n or N=C(R5); n is 0 or 1 and R5 to R8, R10, R100 and R110 are as defined in the specification; p is 1 or 2; R12 is halogen or an optionally substituted aryl, alkyl, alkenyl, alkynyl or -C(O)-R10; OR100 or NR100R110; R14 is H or halogen; R15 is H, halogen, or an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl group; R16 is H; halogen, cyano, or an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl group and R18 is H, halogen, or alkyl; Where R15, R16, R17 and R18 are not all H and when R1, R4, R5, R6, and R7 are each H, R8 is not unsubstituted phenyl. Also described a compound selected from the formula (A).
Patent NZ-514121-A (NZ)
Title: Composite beam with beam supporting profiled sheeting and concrete slab, with reinforcing to prevent longitudinal shear
Inventor: PATRICK MARK
IPC: E04C3/293
Filed: 2001-09-11
Abstract: A composite beam is formed by beam 5 and composite slab over the beam. The composite slab has profiled sheeting 7 with pans 11 separated by ribs 13. The profiled sheeting is positioned in relation to the beam so that the ribs are parallel to the beam or are at an angle of less than 15 degrees.  The composite slab has a concrete layer 29 cast on the profiled sheeting. Shear connectors 15 connect the composite slab to the beam and a reinforcing component 19 to embedded in the concrete slab. The reinforcing component has sections that pass through the tops of the ribs of the profiled sheeting and the tops of the shear connectors to prevent premature failure of the composite beam at the surface.
Patent NZ-515315-A (NZ)
Title: Blocked nucleotides, removable by monochromatic light, for use in nucleic acid sequence analysis
IPC: C07H19/00
Filed: 1998-07-24
Abstract: A nucleotide comprising a blocking group at the 3' position and at the terminal phosphate group of the triphosphate chain, wherein the two blocking groups are removable by monochromatic light of different wavelengths.
Patent NZ-517966-A (NZ)
Title: Sorting items of mail articles by measuring characteristic features and comparing with stored features
Inventor: BAYER THOMAS
IPC: B07C3/14
Filed: 2000-08-08
Abstract: The method relates to the sorting of mail items in several sort passes. In order avoid the need to read the address in each sort pass and in order to avoid printing a machine-readable identification code on each parcel, further elements, which are characteristic of the parcels are established during a first sort pass and memorised together with the distribution codes established during the reading process. During subsequent sort passes, the characteristic elements are simply measured and compared with the stored features. Matching parcels are assigned corresponding distribution codes. A special conveyance system with defined sequences guarantees that only n parcels have to be compared at a time, n representing maximum multiple delivery rate.
Patent NZ-517978-A (NZ)
Title: Composition comprising ASA, calcium and 1,25 DHC for the prevention of colorectal cancer
Inventor: RASKOV HANS HENRIK
IPC: A61P35/00
Filed: 2000-09-29
Abstract: A composition containing acetylsalicyclic acid (ASA), calcium and the vitamin D3 metabolite 1,25 dihydroxy cholecalciferol (1,25 DHC), useful for the treatment of colorectal cancer in a human. Said composition has a synergistic effect such that the amounts of said individual components required to perform their respective roles are reduced.
Patent NZ-518567-A (NZ)
Title: Medicament comprising an inhibitor of 11-beta-hydroxysteroid dehydrogenase in combination with an antigen to induce and/or optimise tolerance induction
Inventor: WILCKENS THOMAS
IPC: A61K48/00
Filed: 2000-10-27
Abstract: Described is a medicament comprising 11-beta -hydroxysteroid dehydrogenase inhibitors such as glycyrrhetinic acid, fluoseamide, flavenoids or derivatives thereof, combined with an antigen in order to improve and optimize tolerance induction.
Patent NZ-519739-A (NZ)
Title: Method for the preparation of citalopram
Inventor: PETERSEN HANS
IPC: C07C213/00
Filed: 1999-12-28
Abstract: Preparation of citalopram (I) and pharmaceutical salts thereof i) By reaction of compound (II), with a diene (III) where X is O, S, SO2, -N=N-, -CO-O-, or -O-CO- followed by oxidation to form citalopram; or ii) By reaction of compound (II) with compound (IV) where R is alkyl or optionally substituted aryl or arylalkyl, followed by conversion of the resulting compound (V) to produce compound (VI), which is converted to compound (VII). Compound (VII) is oxidised to form citalopram (I).
Patent NZ-523133-A (NZ)
Title: Enzyme detection and measurement apparatus and use thereof
Inventor: KRITZLER STEVEN
IPC: G01N33/52
Filed: 2001-06-20
Abstract: A unitary single use analytic device for detecting an enzyme in a liquid at a suitable temperature, the device comprises a support structure for manual manipulation and a composition associated therewith which is responsive to the enzyme in such a way as to cause a change in appearance of the device due to digestion of at least a part of a layer of a composition associated with the support structure to reveal an underlying stratum which is of a different appearance from the digested. The device may be adapted for detecting enzymes from a plurality of classes by having compositions selectively responsive to an enzyme of one class, each responding in such a way as to cause a change in appearance of the device indicative of the presence of an enzyme of a respective class. Also disclosed is a method for estimating the activity of an enzyme in a liquid comprising the steps of inserting a test trip of the present invention into the liquid and measuring the time taken from the moment of insertion until a predetermined change in appearance of the test trip is observed, or noting the appearance of the strip after predetermined time.
Patent NZ-524930-A (NZ)
Title: Elastin peptide compositions and formulations and use of same
Inventor: SANDBERG LAWERENCE B
IPC: A61K38/08
Filed: 1999-03-12
Abstract: A cosmetic composition for treating mammalian tissue, and composition comprising a peptide corresponding to sequence no. 11 (Phenylalanine-Glycine-Proline-Glycine). INTELLECTUAL PROPERTY OFFICE OF NEW ZEALAND ] Patent 524930
Patent NZ-529675-A (NZ)
Title: System and method for pooled electronic purchasing
Inventor: KWEI DAVID WAH HAO
IPC: G06Q30/06
Filed: 2005-04-29
Abstract: A computer executable retail method that comprises:- (a) Sending a page to a prospective purchaser in response to a request, the page being associated with a specific product; (b) Receiving a purchase proposal from the prospective purchaser for direct purchase of the product at a fixed price. The purchase proposal including identifier information of persons nominated by the prospective purchaser and purchase term information selected at least in part by the prospective purchaser, the nominated persons being nominated to contribute to the purchase of the product at a fixed price.
Patent NZ-529734-A (NZ)
Title: Ladder support bracket
Inventor: POLDMAA ARVO
IPC: E06C1/34
Filed: 2002-04-24
Abstract: A ladder support bracket (11) for receiving a rung of a ladder intended to be placed against the gutter (19) of a building and thus restraining it, and hence the ladder, from sideways or downwards movement, is disclosed. The bracket comprises a first region (12) for affixing to a rigid portion of the building, a second region (13) which spans the gutter and a third region (14) in the form of a cradle for receiving the rung of the ladder. The ladder support bracket preferably has the first region for fixing the bracket to a rigid portion of the building in the form of a relatively planar sheet like portion which may be attached by suitable means such as screws (22, 23) or the like to the rafters (18) or other timber members of the roof support structure of the building such as battens (21), this portion then being covered by the roofing material whether tiles or metal roofing.